Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells

Gynecologic Oncology

Volumn 97, Issue 3, 2005, Pages 796-806

  Bélanger, Sylvie ^a   Côté, Marceline ^a   Lane, Denis ^a   L'Espérance, Sylvain ^a   Rancourt, Claudine ^a   Piché, Alain ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Apoptosis; Bcl 2; Cell cycle; Cisplatin; Ovarian cancer; Single chain antibodies

Indexed keywords

DOXYCYCLINE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; OVARY CARCINOMA; PRIORITY JOURNAL; STAINING;

APOPTOSIS; CELL DIVISION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; G2 PHASE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; S PHASE;

EID: 20444441843     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.02.018     Document Type: Article

References (34)

1. J. Reed Bcl-2: prevention of apoptosis as a mechanism of drug resistance Hematol./Oncol. Clin. North Am. 9 1995 451 473
2. E. Yang, and S.J. Korsmeyer Molecular thanatopsis: a discourse on the BCL-2 family and cell death Blood 88 1996 386 401
3. A. Gross, J.M. McDonnell, and S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis Genes Dev. 13 1999 1899 1911
4. J.M. Adams, and S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1998 1322 1326
5. J.C. Reed Double identity for proteins of the Bcl-2 family Nature 378 1997 773 776
6. S.D. Mazel, B. Burtum, and H.T. Petrie Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death J. Exp. Med. 183 1996 2210 2225
7. G. Vairo, K.M. Innes, and J.M. Adams Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival Oncogene 13 1996 1511 1519
8. C. Borner Diminished cell proliferation associated with the death-protective activity of Bcl-2 J. Biol. Chem. 271 1996 12695 12698
9. L.A. O'Reilly, D.S.C. Huang, and A. Strasser The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry EMBO J. 15 1996 6979 6990
10. E.F. Lind, J. Wayne, Q.-Z. Wang, Staeva, A. Stolzer, and H.T. Petrie Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions J. Immunol. 162 1999 5374 5379
11. Kip1, pRB relative p130, and altered E2F regulation Mol. Cell. Biol. 20 2000 4745 4753
12. C. Greider, A. Chattopadhyay, C. Parkhurst, and E. Yang Bcl-XL and Bcl-2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases Oncogene 21 2002 7765 7775
13. D.S.C. Huang, L.A. O'Reilly, A. Strasser, and S. Cory The anti-apoptotic function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry EMBO J. 16 1997 4628 4638
14. K.L. Murphy, F.S. Kittrell, J.P. Gay, R. Jäger, D. Medina, and J.M. Rosen Bcl-2 expression delays mammary tumor development in dimethylbenz(a) anthracene-treated transgenic mice Oncogene 18 1999 6597 6604
15. K.G. Biden, L.A. Simms, M. Cummings, R. Buttenshaw, E. Schoch, and J. Searle Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability Oncogene 18 1999 1245 1249
16. P.A. Furth, U. Bar-Peled, M. Li, A. Lewis, R. Laucirica, and R. Jäger Lost of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model Oncogene 18 1999 6589 6596
17. K. Kasono, Y. Heike, J.L. Xiang, A. Piché, H.G. Kim, and M. Hagiwara Tetracycline-induced expression of an anti-c-myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562 Cancer Gene Ther. 7 2000 151 159
18. J.S. Yu, M. Sena-Esteves, W. Paulus, S.O. Breakefield, and S.A. Reeves Retroviral delivery and tetracycline-dependent expression of IL-1β-converting enzyme (ICE) in a rat glioma model provides controlled induction of apoptotic death in tumor cells Cancer Res. 56 1996 5423 5427
19. A. Piché, J. Grim, C. Rancourt, J. Gomez-Navarro, J.C. Reed, and D.T. Curiel Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7 Cancer Res. 58 1998 2134 2140
20. D. Yu, J.K. Wolf, D. Scanlon, J.E. Price, and M.-C. Hung Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A Cancer Res. 53 1993 891 898
21. K.M. Henkels, and J.J. Turchi Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines Cancer Res. 59 1999 3077 3083
22. A. Piché, K. Kasono, F. Johaning, T.J. Curiel, and D.T. Curiel Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody Gene Ther. 5 1998 1171 1179
23. E.H. Cheng, M.C. Wei, S. Weller, R.A. Flavell, T.W. Mak, and T. Lindsten Bcl-2, Bcl-XL sequester BH3 domain-only molecules preventing Bax- and Bak-mediated mitochondrial apoptosis Mol. Cell. 8 2001 705 711
24. A. Fanidi, E.A. Harrington, and G.I. Evan Cooperative interaction between c-myc and bcl-2 proto-oncogene Nature 359 1992 554 556
25. A.-O. Hueber, and G.I. Evan Traps to catch unwary oncogenes Trends Genet. 9 1998 364 367
26. G. Nunez, I. London, D. Hockenbery, M. Alexander, J.P. McKearn, and S.J. Korsmeyer Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines J. Immunol. 144 1990 3602 3610
27. L. Rao, M. Debbas, P. Sabbatini, D. Hockenbery, S.J. Korsmeyer, and E. White The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19kkDa and Bcl-2 proteins Proc. Natl. Acad. Sci. U. S. A. 89 1993 7742 7746
28. T. Lithgow, R. van Driel, J.F. Bertram, and A. Strasser The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane Cell Growth Differ. 5 1994 411 417
29. C. Borner, L. Martinou, C. Mattmann, M. Irmler, E. Schaerer, and J.-C. Martinou The protein bcl-2α does not require membrane attachment, but two conserved domains to suppress apoptosis J. Cell. Biol. 126 1994 1059 1068
30. L.C. Lee, J.J. Hunter, A. Mujeeb, C. Turck, and T.G. Parslow Evidence for α-helical conformation of an essential N-terminal region in the human Bcl2 protein J. Biol. Chem. 271 1996 23284 23288
31. J.O. Herod, A.G. Eliopoulos, J. Warwick, G. Niedobitek, L.S. Young, and D.J. Kerr The prognostic significance of bcl-2 and p53 expression in ovarian carcinoma Cancer Res. 56 1996 2178 2184
32. D. Marx, C. Binder, H. Meden, T. Lenthe, T. Ziemek, and T. Hiddemann Differential expression of apoptosis associated genes Bax and Bcl-2 in ovarian cancer AntiCancer Res. 17 1997 2233 2240
33. M. Marone, G. Scambia, S. Mozzetti, G. Ferrandina, S. Iacovella, and A. Depasqua Bcl-2, Bax, Bcl-XL, and Bcl-XS expression in normal and neoplastic ovarian tissues Clin. Cancer Res. 4 1998 517 524
34. S.J. Kosrsmeyer Regulators of cell death Trends Genet. 11 1995 101 105